Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)

Clinical trial NCT04872101 · COMPLETED

Trial details

NCT number: NCT04872101
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hand Eczema

Start date: 2021-05-25
Primary completion: 2022-12-27
Enrollment: 473

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.